Answer | % Correct |
---|---|
Adrenaline | 62%
|
Insulin | 57%
|
Growth hormone | 48%
|
Dopamine | 43%
|
Follicle stimulating hormone | 38%
|
Melatonin | 38%
|
Oxytocin | 38%
|
Antidiuretic hormone | 33%
|
Glucagon | 33%
|
Noradrenaline | 33%
|
Thyroid stimulating hormone | 33%
|
Luteinizing hormone | 29%
|
Prolactin | 29%
|
Calcitonin | 24%
|
Ghrelin | 24%
|
Gastrin | 19%
|
Parathyroid hormone | 19%
|
Thyroxine | 19%
|
Adrenocorticotropic hormone | 14%
|
Angiotensin | 14%
|
Human chorionic gonadotropin | 14%
|
Leptin | 14%
|
Prostaglandins | 10%
|
Gonadotropin releasing hormone | 10%
|
Relaxin | 10%
|
Renin | 10%
|
Somatostatin | 10%
|
Adiponectin | 5%
|
Amylin | 5%
|
Anti-Müllerian hormone | 5%
|
Atrial natriuretic peptide | 5%
|
Cholecystokinin | 5%
|
Cortistatin | 5%
|
Endothelin | 5%
|
Enkephalin | 5%
|
Erythropoietin | 5%
|
Galanin | 5%
|
Glucagon-like peptide | 5%
|
Growth hormone releasing hormone | 5%
|
Guanylin | 5%
|
Hepcidin | 5%
|
Human placental lactogen | 5%
|
Inhibin | 5%
|
Insulin-like growth factor | 5%
|
Leukotrienes | 5%
|
Lipotropin | 5%
|
Melanocyte stimulating hormone | 5%
|
Motilin | 5%
|
Orexin | 5%
|
Osteocalcin | 5%
|
Ovulation/testosterone production | 5%
|
Pancreatic polypeptide | 5%
|
Prolactin releasing hormone | 5%
|
Prostacyclin | 5%
|
Secretin | 5%
|
Thrombopoietin | 5%
|
Thromboxane | 5%
|
Thyrotropin releasing hormone | 5%
|
Triiodothyronine | 5%
|
Uroguanylin | 5%
|
Vasoactive intestinal peptide | 5%
|
ACTH release | 0%
|
Action potential inhibition | 0%
|
Appetite | 0%
|
Bicarbonate secretion | 0%
|
Brain natriuretic peptide | 0%
|
Breast milk release, vaginal contraction | 0%
|
Ca2+ bone construction | 0%
|
Corpus luteum maintenance | 0%
|
Corticosteroid synthesis | 0%
|
Corticotropin releasing hormone | 0%
|
Decrease of appetite | 0%
|
Depression of neuronal activity | 0%
|
Digestion inhibition | 0%
|
Erythrocyte production | 0%
|
ECL cell stimulation | 0%
|
Fatty acid and glucose regulation | 0%
|
Fight-or-flight reaction | 0%
|
FSH, LH release | 0%
|
FSH production inhibition | 0%
|
Gastric acid secretion | 0%
|
Gastric activity stimulation | 0%
|
Gastric inhibitory polypeptide | 0%
|
GH release | 0%
|
GH, TRH, gut hormones release inhibition | 0%
|
Glucose intake | 0%
|
Glycogenolysis, gluconeogenesis | 0%
|
Graafian follicle maturation/spermatogenesis | 0%
|
Growth and cell reproduction | 0%
|
Heart contractility, vasodilation | 0%
|
Increased metabolism | 0%
|
Insulin, IGF production | 0%
|
Insulin-like effects | 0%
|
Insulin secretion | 0%
|
Insulin synthesis and release | 0%
|
Intestinal water transport regulation | 0%
|
Iron export inhibition | 0%
|
Lipolysis | 0%
|
Melanogenesis | 0%
|
Milk production | 0%
|
Muscle function | 0%
|
PAC activating peptide | 0%
|
Pain regulation | 0%
|
Pancreatic secretion regulation | 0%
|
Platelet production | 0%
|
Prolactin and TRH release inhibition | 0%
|
Prolactin release | 0%
|
Prolactin release inhibition | 0%
|
RAS activation | 0%
|
Reducing blood pressure | 0%
|
Release of bile, pancreatic enzymes | 0%
|
Release of Ca2+ from bone | 0%
|
Renal water transport regulation | 0%
|
Retention of water | 0%
|
Sleep-wake cycle | 0%
|
Smooth muscle contraction | 0%
|
Sodium excretion increase | 0%
|
T3, T4 secretion | 0%
|
TSH, prolactin release | 0%
|
Unclear | 0%
|
Vascular permeability increase | 0%
|
Vasoconstriction, aldosterone release | 0%
|
Vasoconstriction, platelet aggregation | 0%
|
Vasodilation | 0%
|
Vasodilation, platelet inhibition | 0%
|
Wakefulness | 0%
|
Copyright H Brothers Inc, 2008–2024
Contact Us | Go To Top | View Mobile Site